Background Postpartum haemorrhage (PPH) is the leading cause of maternal mortality
worldwide. Prophylactic uterotonic agents can prevent PPH, and are routinely …

BACKGROUND Postpartum haemorrhage (PPH) is the leading cause of maternal mortality
worldwide. Prophylactic uterotonic drugs can reduce blood loss and are routinely …

Background: Postpartum hemorrhage (PPH) remains a common cause of maternal mortality
worldwide. Medical intervention plays an important role in the prevention and treatment of …

Abstract Building upon the World Health Organization's ExpandNet framework, 12 key
principles of scale‐up have emerged from the implementation of maternal and newborn …

Introduction: Uterotonic drugs are recommended for the prevention and treatment of
postpartum hemorrhage (PPH), and oxytocin is considered the gold standard for both …

Purpose The commonest surgical procedure for women is cesarean delivery. Postpartum
hemorrhage and intra-operative blood during cesarean delivery is a major concern to all …

OBJECTIVE: To determine the association of hemoglobin (Hb) and plasma nitrite (PN)
concentrations on admission to the delivery ward with the occurrence of atonic postpartum …

Background Shivering and fever are common side effects of misoprostol. An unexpectedly
high rate of fever above 40° C was documented among Ecuadorian women given treatment …

Aim: To evaluate the external aortic compression device (EACD) as a first aid to control
postpartum hemorrhage (PPH). Methods: Three hundred women whose deliveries were …

Aim: To compare maternal mortality and morbidity due to postpartum hemorrhage (PPH) at
Minia University Maternity Hospital, El‐Minia, Egypt, before and while external aortic …